Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS)

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Shimomura, Yumi ^a   Okumura, Kayo ^a,d   Murayama, Somay Y ^b   Yagi, Junji ^c   Ubukata, Kimiko ^b   Kirikae, Teruo ^a   Miyoshi Akiyama, Tohru ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; BACTERIAL TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE CLUSTER; GENE SEQUENCE; GENETIC RECOMBINATION; GENOME ANALYSIS; HORIZONTAL GENE TRANSFER; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PROTEIN BINDING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STREPTOCOCCUS DYSGALACTIAE EQUISIMILIS; TOXIC SHOCK SYNDROME; ANIMAL; FEMALE; GENETICS; HUMAN; MICROBIOLOGY; MOUSE; PATHOGENICITY; PROPHAGE; SEPTIC SHOCK; STREPTOCOCCUS; VIROLOGY;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A'; STREPTOCOCCUS SP. 'GROUP G';

ANIMALS; BACTERIAL TOXINS; FEMALE; GENOME, BACTERIAL; HUMANS; MICE; PROPHAGES; SHOCK, SEPTIC; STREPTOCOCCUS; VIRULENCE FACTORS;

EID: 78651084774     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-17     Document Type: Article

References (80)

1. Lindbaek M, Hoiby EA, Lermark G, Steinsholt IM, Hjortdahl P. Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 2005, 55:615-619. 1463235, 16105370.
2. Bramhachari PV, Kaul SY, McMillan DJ, Shaila MS, Karmarkar MG, Sriprakash KS. Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol 2010, 59:220-223. 10.1099/jmm.0.015644-0, 19833781.
3. Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P, Daily P, Reingold A, Farley MM. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009, 48:706-712. 10.1086/597035, 19187026.
4. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005, 11:569-576. 10.1111/j.1469-0691.2005.01169.x, 15966976.
5. Lopardo HA, Vidal P, Sparo M, Jeric P, Centron D, Facklam RR, Paganini H, Pagniez NG, Lovgren M, Beall B. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J Clin Microbiol 2005, 43:802-807. 10.1128/JCM.43.2.802-807.2005, 548053, 15695683.
6. Sunaoshi K, Murayama SY, Adachi K, Yagoshi M, Okuzumi K, Chiba N, Morozumi M, Ubukata K. Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections. J Med Microbiol 2010, 59:82-88. 10.1099/jmm.0.013201-0, 19745030.
7. Sunaoshi KS, Aburahashi H, Kobayashi R, Yamamoto Y, Okuzumi K, Yoshida A, Misawa Y, Adachi K, Ubukata K. Emm typing by genetic identification of Streptococcus dysgalactiae subsp. equisimilis and susceptibility to oral antibiotics. Kansenshogaku Zasshi 2006, 80:488-495.
8. Takahashi T, Ubukata K, Watanabe H. Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features. J Infect Chemother 2010,
9. Reissmann S, Friedrichs C, Rajkumari R, Itzek A, Fulde M, Rodloff AC, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP. Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis 2010, 16:656-663.
10. Dawson ED, Taylor AW, Smagala JA, Rowlen KL. Molecular detection of Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis. Mol Biotechnol 2009, 42:117-127. 10.1007/s12033-009-9143-2, 19156548.
11. Hilmarsdottir I, Valsdottir F. Molecular typing of Beta-hemolytic streptococci from two patients with lower-limb cellulitis: identical isolates from toe web and blood specimens. J Clin Microbiol 2007, 45:3131-3132. 10.1128/JCM.00532-07, 2045304, 17609319.
12. Horii T, Izumida S, Takeuchi K, Tada T, Ishikawa J, Tsuboi K. Acute peritonitis and salpingitis associated with streptococcal toxic shock syndrome caused by Lancefield group G alpha-haemolytic Streptococcus dysgalactiae subsp. equisimilis. J Med Microbiol 2006, 55:953-956. 10.1099/jmm.0.46507-0, 16772425.
13. Kumar A, Sandoe J, Kumar N. Three cases of vertebral osteomyelitis caused by Streptococcus dysgalactiae subsp. equisimilis. J Med Microbiol 2005, 54:1103-1105. 10.1099/jmm.0.46061-0, 16192443.
14. Misawa Y, Okugawa S, Ubukata K, Okuzumi K, Okada M, Moriya K, Koike K. A case of severe necrotizing cellulitis caused by group G Streptococcus dysgalactiae subsp. equisimilis. Kansenshogaku Zasshi 2006, 80:436-439.
15. Moser C, Andresen K, Kjerulf A, Salamon S, Kemp M, Christensen JJ. Infective Arthritis: Bacterial 23S rRNA Gene Sequencing as a Supplementary Diagnostic Method. Open Microbiol J 2008, 2:85-88. 10.2174/1874285800802010085, 2593041, 19088916.
16. Savini V, Catavitello C, Talia M, Manna A, Pompetti F, Di Bonaventura G, Di Giuseppe N, Febbo F, Balbinot A, Di Zacomo S, Esattore F, D'Antonio D. Beta-lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis Pharyngitis patients. J Clin Microbiol 2008, 46:814-816. 10.1128/JCM.00985-07, 2238097, 18057124.
17. Mott ML, Berger JM. DNA replication initiation: mechanisms and regulation in bacteria. Nat Rev Microbiol 2007, 5:343-354. 10.1038/nrmicro1640, 17435790.
18. Nakagawa I, Kurokawa K, Yamashita A, Nakata M, Tomiyasu Y, Okahashi N, Kawabata S, Yamazaki K, Shiba T, Yasunaga T, Hayashi H, Hattori M, Hamada S. Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res 2003, 13:1042-1055. 10.1101/gr.1096703, 403657, 12799345.
19. Holden MT, Scott A, Cherevach I, Chillingworth T, Churcher C, Cronin A, Dowd L, Feltwell T, Hamlin N, Holroyd S, Jagels K, Moule S, Mungall K, Quail MA, Price C, Rabbinowitsch E, Sharp S, Skelton J, Whitehead S, Barrell BG, Kehoe M, Parkhill J. Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain manfredo. J Bacteriol 2007, 189:1473-1477. 10.1128/JB.01227-06, 1797351, 17012393.
20. McShan WM, Ferretti JJ, Karasawa T, Suvorov AN, Lin S, Qin B, Jia H, Kenton S, Najar F, Wu H, Scott J, Roe BA, Savic DJ. Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J Bacteriol 2008, 190:7773-7785. 10.1128/JB.00672-08, 2583620, 18820018.
21. Banks DJ, Porcella SF, Barbian KD, Beres SB, Philips LE, Voyich JM, DeLeo FR, Martin JM, Somerville GA, Musser JM. Progress toward characterization of thegroup A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J Infect Dis 2004, 190:727-738. 10.1086/422697, 15272401.
22. Beres SB, Sesso R, Pinto SW, Hoe NP, Porcella SF, Deleo FR, Musser JM. Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One 2008, 3:e3026. 10.1371/journal.pone.0003026, 2516327, 18716664.
23. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM. Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005, 192:771-782. 10.1086/432514, 16088826.
24. Green NM, Zhang S, Porcella SF, Nagiec MJ, Barbian KD, Beres SB, LeFebvre RB, Musser JM. Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 2005, 192:760-770. 10.1086/430618, 16088825.
25. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, Sturdevant DE, Ricklefs SM, Porcella SF, Parkins LD, Beres SB, Campbell DS, Smith TM, Zhang Q, Kapur V, Daly JA, Veasy LG, Musser JM. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002, 99:4668-4673. 10.1073/pnas.062526099, 123705, 11917108.
26. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321:960-964. 10.1126/science.1159689, 18703739.
27. Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008, 322:1843-1845. 10.1126/science.1165771, 2695655, 19095942.
28. Holden MT, Heather Z, Paillot R, Steward KF, Webb K, Ainslie F, Jourdan T, Bason NC, Holroyd NE, Mungall K, Quail MA, Sanders M, Simmonds M, Willey D, Brooks K, Aanensen DM, Spratt BG, Jolley KA, Maiden MC, Kehoe M, Chanter N, Bentley SD, Robinson C, Maskell DJ, Parkhill J, Waller AS. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog 2009, 5:e1000346. 10.1371/journal.ppat.1000346, 2654543, 19325880.
29. van der Ploeg JR. Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology 2009, 155:1966-1976. 10.1099/mic.0.027508-0, 19383692.
30. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science 2010, 327:167-170. 10.1126/science.1179555, 20056882.
31. Davies MR, McMillan DJ, Beiko RG, Barroso V, Geffers R, Sriprakash KS, Chhatwal GS. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 2007, 44:1442-1454. 10.1086/516780, 17479940.
32. McMillan DJ, Vu T, Bramhachari PV, Kaul SY, Bouvet A, Shaila MS, Karmarkar MG, Sriprakash KS. Molecular markers for discriminating Streptococcus pyogenes and S. dysgalactiae subspecies equisimilis. Eur J Clin Microbiol Infect Dis 2010, 29:585-589. 10.1007/s10096-010-0899-x, 20221892.
33. Betschel SD, Borgia SM, Barg NL, Low DE, De Azavedo JC. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S. Infect Immun 1998, 66:1671-1679. 108104, 9529097.
34. Flanagan J, Collin N, Timoney J, Mitchell T, Mumford JA, Chanter N. Characterization of the haemolytic activity of Streptococcus equi. Microb Pathog 1998, 24:211-221. 10.1006/mpat.1997.0190, 9533893.
35. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. Autophagy defends cells against invading group A Streptococcus. Science 2004, 306:1037-1040. 10.1126/science.1103966, 15528445.
36. Zhao J, Hayashi T, Saarinen S, Papageorgiou AC, Kato H, Imanishi K, Kirikae T, Abe R, Uchiyama T, Miyoshi-Akiyama T. Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae. Infect Immun 2007, 75:1721-1729. 10.1128/IAI.01183-06, 1865666, 17283088.
37. Kamezawa Y, Nakahara T, Nakano S, Abe Y, Nozaki-Renard J, Isono T. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun 1997, 65:3828-3833. 175546, 9284159.
38. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, Russell HH, Turner C, Cohen J, Faulkner L, Sriskandan S. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis 2005, 192:783-790. 10.1086/432485, 16088827.
39. Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008, 49:21-31.
40. Lahteenmaki K, Kuusela P, Korhonen TK. Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 2001, 25:531-552. 10.1016/S0168-6445(01)00067-5, 11742690.
41. Chaussee MS, Gerlach D, Yu CE, Ferretti JJ. Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes. Infect Immun 1993, 61:3719-3723. 281069, 8359893.
42. Falugi F, Zingaretti C, Pinto V, Mariani M, Amodeo L, Manetti AG, Capo S, Musser JM, Orefici G, Margarit I, Telford JL, Grandi G, Mora M. Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypes. J Infect Dis 2008, 198:1834-1841. 10.1086/593176, 18928376.
43. Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, Manetti AG, Maggi T, Taddei AR, Grandi G, Telford JL. Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci USA 2005, 102:15641-15646. 10.1073/pnas.0507808102, 1253647, 16223875.
44. Lauer P, Rinaudo CD, Soriani M, Margarit I, Maione D, Rosini R, Taddei AR, Mora M, Rappuoli R, Grandi G, Telford JL. Genome analysis reveals pili in Group B Streptococcus. Science 2005, 309:105. 10.1126/science.1111563, 15994549.
45. Bjorck L, Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 1984, 133:969-974.
46. Terao Y, Yamaguchi M, Hamada S, Kawabata S. Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils. J Biol Chem 2006, 281:14215-14223. 10.1074/jbc.M513408200, 16565520.
47. Stollerman GH, Dale JB. The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 2008, 46:1038-1045. 10.1086/529194, 18444821.
48. Kumari K, Weigel PH. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis. J Biol Chem 1997, 272:32539-32546. 10.1074/jbc.272.51.32539, 9405467.
49. Starr CR, Engleberg NC. Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infect Immun 2006, 74:40-48. 10.1128/IAI.74.1.40-48.2006, 1346594, 16368955.
50. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, Feramisco J, Nizet V. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 2006, 16:396-400. 10.1016/j.cub.2005.12.039, 16488874.
51. Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-Normark B. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol 2006, 16:401-407. 10.1016/j.cub.2006.01.056, 16488875.
52. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535. 10.1126/science.1092385, 15001782.
53. Hasegawa T, Minami M, Okamoto A, Tatsuno I, Isaka M, Ohta M. Characterization of a virulence-associated and cell-wall-located DNase of Streptococcus pyogenes. Microbiology 2010, 156:184-190. 10.1099/mic.0.031955-0, 19850619.
54. Nitsche DP, Johansson HM, Frick IM, Morgelin M. Streptococcal protein FOG, a novel matrix adhesin interacting with collagen I in vivo. J Biol Chem 2006, 281:1670-1679. 10.1074/jbc.M506776200, 16278217.
55. Barroso V, Rohde M, Davies MR, Gillen CM, Nitsche-Schmitz DP, Dinkla K, Chhatwal GS. Identification of active variants of PARF in human pathogenic group C and group G streptococci leads to an amended description of its consensus motif. Int J Med Microbiol 2009, 299:547-553. 10.1016/j.ijmm.2009.04.004, 19520603.
56. Binks M, Sriprakash KS. Characterization of a complement-binding protein, DRS, from strains of Streptococcus pyogenes containing the emm12 and emm55 genes. Infect Immun 2004, 72:3981-3986. 10.1128/IAI.72.7.3981-3986.2004, 427425, 15213143.
57. Sagar V, Kumar R, Ganguly NK, Menon T, Chakraborti A. DRS is far less divergent than streptococcal inhibitor of complement of group A streptococcus. J Bacteriol 2007, 189:2933-2935. 10.1128/JB.01619-06, 1855820, 17237170.
58. Fernie-King BA, Seilly DJ, Davies A, Lachmann PJ. Streptococcal inhibitor of complement inhibits two Additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 2002, 70:4908-4916. 10.1128/IAI.70.9.4908-4916.2002, 128256, 12183536.
59. Hartas J, Sriprakash KS. Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein. Microb Pathog 1999, 26:25-33. 10.1006/mpat.1998.0244, 9973578.
60. Caswell CC, Barczyk M, Keene DR, Lukomska E, Gullberg DE, Lukomski S. Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins alpha2beta1 and alpha11beta1. J Biol Chem 2008, 283:36168-36175. 10.1074/jbc.M806865200, 2605992, 18990704.
61. Kimoto H, Fujii Y, Yokota Y, Taketo A. Molecular characterization of NADase-streptolysin O operon of hemolytic streptococci. Biochim Biophys Acta 2005, 1681:134-149.
62. Madden JC, Ruiz N, Caparon M. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria. Cell 2001, 104:143-152. 10.1016/S0092-8674(01)00198-2, 11163247.
63. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13:470-511. 10.1128/CMR.13.3.470-511.2000, 88944, 10885988.
64. Miyoshi-Akiyama T, Zhao J, Kikuchi K, Kato H, Suzuki R, Endoh M, Uchiyama T. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci. J Infect Dis 2003, 187:1876-1887. 10.1086/375348, 12792864.
65. Pinho MD, Melo-Cristino J, Ramirez M. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness. J Clin Microbiol 2006, 44:841-846. 10.1128/JCM.44.3.841-846.2006, 1393098, 16517864.
66. Kittang BR, Langeland N, Mylvaganam H. Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. APMIS 2008, 116:457-464. 10.1111/j.1600-0463.2008.00976.x, 18754319.
67. Bentley RW, Leigh JA, Collins MD. Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences. Int J Syst Bacteriol 1991, 41:487-494. 10.1099/00207713-41-4-487, 1720654.
68. Chatellier S, Harel J, Zhang Y, Gottschalk M, Higgins R, Devriese LA, Brousseau R. Phylogenetic diversity of Streptococcus suis strains of various serotypes as revealed by 16S rRNA gene sequence comparison. Int J Syst Bacteriol 1998, (48 Pt 2):581-589.
69. Sachse S, Seidel P, Gerlach D, Gunther E, Rodel J, Straube E, Schmidt KH. Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol Med Microbiol 2002, 34:159-167. 10.1111/j.1574-695X.2002.tb00618.x, 12381468.
70. Ikebe T, Wada A, Inagaki Y, Sugama K, Suzuki R, Tanaka D, Tamaru A, Fujinaga Y, Abe Y, Shimizu Y, Watanabe H. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect Immun 2002, 70:3227-3233. 10.1128/IAI.70.6.3227-3233.2002, 128029, 12011018.
71. Miyoshi-Akiyama T, Ikebe T, Watanabe H, Uchiyama T, Kirikae T, Kawamura Y. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate. J Infect Dis 2006, 193:1677-1684. 10.1086/504263, 16703511.
72. Laslett D, Canback B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res 2004, 32:11-16. 10.1093/nar/gkh152, 373265, 14704338.
73. Xu Z, Hao B. CVTree update: a newly designed phylogenetic study platform using composition vectors and whole genomes. Nucleic Acids Res 2009, 37:W174-8. 10.1093/nar/gkp278, 2703908, 19398429.
74. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795. 10.1016/j.jmb.2004.05.028, 15223320.
75. Boekhorst J, de Been MW, Kleerebezem M, Siezen RJ. Genome-wide detection and analysis of cell wall-bound proteins with LPxTG-like sorting motifs. J Bacteriol 2005, 187:4928-4934. 10.1128/JB.187.14.4928-4934.2005, 1169495, 15995208.
76. Grissa I, Vergnaud G, Pourcel C. CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res 2007, 35:W52-7. 10.1093/nar/gkm360, 1933234, 17537822.
77. Kuo CF, Wu JJ, Lin KY, Tsai PJ, Lee SC, Jin YT, Lei HY, Lin YS. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 1998, 66:3931-3935. 108455, 9673282.
78. Gryllos I, Grifantini R, Colaprico A, Jiang S, Deforce E, Hakansson A, Telford JL, Grandi G, Wessels MR. Mg(2+) signalling defines the group A streptococcal CsrRS (CovRS) regulon. Mol Microbiol 2007, 65:671-683. 10.1111/j.1365-2958.2007.05818.x, 17608796.
79. Graham MR, Virtaneva K, Porcella SF, Gardner DJ, Long RD, Welty DM, Barry WT, Johnson CA, Parkins LD, Wright FA, Musser JM. Analysis of the transcriptome ofgroup A Streptococcus in mouse soft tissue infection. Am J Pathol 2006, 169:927-942. 10.2353/ajpath.2006.060112, 1698835, 16936267.
80. Hytonen J, Haataja S, Finne J. Streptococcus pyogenes glycoprotein-binding strepadhesin activity is mediated by a surface-associated carbohydrate-degrading enzyme, pullulanase. Infect Immun 2003, 71:784-793. 10.1128/IAI.71.2.784-793.2003, 145387, 12540558.